Cart is empty The cytoskeleton protein septin-3 has been identified as a novel target antigen of autoantibodies in patients with paraneoplastic cerebellar ataxia. The new biomarker was discovered in a collaborative study between scientists at EUROIMMUN, the University of Heidelberg and further clinics…
Der Beitrag Novel autoantibody against septin-3 discovered in neurological disease erschien zuerst auf EUROIMMUNBlog.